Educator Program

Discussion in 'Novo Nordisk' started by anonymous, Aug 11, 2017 at 3:43 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Education Managers should go away. Period. Educators should report to sales. Now, don't get your panties in a wad. We all know you're not in sales and you're not selling.

    Do your education, but keep the reporting streamlined. Then we all know who is doing what and when.
     

  2. anonymous

    anonymous Guest

    Your point is well taken. I think it's something that might have already been or is currently being considered. Although I'm not too sure that a lot of DE's would hang around if they found themselves directly reported to DBM's. I'm sure some would stay, but IMHO most would leave. DE's can find jobs elsewhere and go back to being a practicing clinician.

    They could also flip your idea. Keep The DEP Managers and cut DBM's and have DCS's report to DEM's. DE Managers have sales experience.

    Or they could cut DE Managers, keep The DE's, and reduce Rep headcount all at the same time! Looks to me like there are lots of ways to streamline.
     
  3. anonymous

    anonymous Guest

    my DEM has no sales experience. At. All. And it shows. Every day.

    Many DEMs were promoted with no pharma experience, no leadership experience. I don't need a DEM to help me in offices, approve expenses or guide me.

    We need strong leadership and need to be aligned with sales to protect our jobs.
     
  4. anonymous

    anonymous Guest

    Biopharm cut their educator program last year. Ours is going to be cut this year.
     
  5. anonymous

    anonymous Guest

    Your DEM lack of sales experience shows everyday and you haven't left Novo? Are you crazy? Why are you still here? I'd be long gone.
     
  6. anonymous

    anonymous Guest

    This program straight up sucks monkey bits now. My DEM is the biggest butt kisser in the history of butt kissing! He strokes the ego of every sales DBM in his sight. The lies in this program are so enormous it's earth shaking at times. Once upon a time there was ACTUAL education with patients. Today it's data, spreadsheets, and cover-ups galore. I smell a downsize coming and frankly it couldn't be more needed. With access so poor and these territories the size of my underwear, I can smell the fart of the DE on top of me and all 3 DCS's, 3EDCS's, AND 2 HSDCS's. WTH! Downsize this program Novo. Can't wait to hear what the "plans" are on Thursday.
     
  7. anonymous

    anonymous Guest

    We're not really interested in the peanut gallery's opinions on what should happen and to whom. And since when did DCSs and DBMs dictate strategy here? Stay in your lane: Quiznos or Panera tomorrow and Tuesday, or the other way 'round?
     
  8. anonymous

    anonymous Guest

    None of those things is ever going to happen.
     
  9. anonymous

    anonymous Guest


    Isn't CafePharma, as a whole, the "peanut gallery" replying to a thread to start a conversation.

    I agree that the ROI for the EP is slim to none. Some educators are better at selling NNI's products than others, instead of "getting patients moved to injectables". They are doing what all the E/HS/DCSs are doing, selling against DPP4s, SGLT2s, SUs and the like. To be real, it would be a logical business decision to move on from that program.
     
  10. anonymous

    anonymous Guest

    You hope not anyway. Truth is nobody knows what's going to happen. Keep your fingers crossed.
     
  11. anonymous

    anonymous Guest

    If its the logical business decision, then we won't do it. Which of these decisions made good sense in 2013-2016? Keep in mind that in that time frame we shoulda known that biosim Lantus would get approved, and that ESI would be kicking our ass with it.
    • Approving the DCA team
    • Fleshing out the Educator program so that the team is the same size as a small biotech company's PC sales force
    • Adding Hs and Es
    • "APPARENT" collusion on steady and regular price increases with Sanofi and Lilly
    • Allowing top-echelon (Scanlon, Camille, Sakdalan, Andy, many more) to run major departments as their personal fiefdoms
    • Adding hundreds of AEs and adding new layer of management
    • Paying Paula D all that money and not cutting ties with her immediately after her poo-poo undies (hiding that she had T2DM from her fans, making racist comments) became exposed
    Hey, I'm just a mid-level manager here, but DAMN…with so many here bitching and complaining about decreased access and customer complaints about patient complaints about prices, couldn't ONE of our consulting partners told someone in Plainsboro that we needed to prepare for a pending storm? We were acting like it was 1999, just a few years ago. And now a significant percentage of us will feel the sting by getting our positions cut.
     
  12. anonymous

    anonymous Guest

    I love the above post. It's easily the single best post I've read on CP in years!

    My guess is that the consulting partners didn't say anything to anybody for fear of being fired. Why would they want to kill the goose that lays the golden eggs?
     
  13. anonymous

    anonymous Guest

     
  14. Flex Toucher

    Flex Toucher Guest



    DUDE you are brilliant and nailed it. We have been sitting back laughing during POAs and keeping Novo fuck-up lists---and you nailed it. Like seriously, why is Novo so dense? A consulting partner to clue the fucksticks in? I am all about agreeing with you. Lets fix it all, shall we?
    1. Decrease the number of speaker programs per year, and the cap
    2. ALL sales geographies are TWO reps, yes TWO. DCS? TWO. EDCS? TWO
    3. Get rid of HDCS. All of them.
    4. Managers cover 10 reps. Yep folks, just like the good old days 10
    5. Get rid of all educators. ALL of them.
    6. ONE travel meeting per year, all others will be regional
    7. Reduce sample quantities.
    8. CUT prices of our products.
    9. GET RID OF RSMS---why why why is this the only company I have worked for where the RBD has a glorified secretary????
    10. Let the fiefdoms fall....
     
  15. anonymous

    anonymous Guest

    Ummm, we don't have RSMs...
     
  16. anonymous

    anonymous Guest

    I disagree on one point. There is no need for 2 DCS and 2 EDCS. Consolidate these two and let us call on everyone.
     
  17. anonymous

    anonymous Guest

    BAHAHAHAHAHAHAHA! DCS calling on Endos! BAHAHAHAHAHA! Not that there is funny!
     
  18. anonymous

    anonymous Guest

    From the beginning of pharma rep time until reach and frequency stupidness started to hit its peak, in most companies territory reps called on community hospitals, ALL relevant sub-specialists (Psych, Orthos, OB/Gyn, Hem/Onc, ID, Endos) and retail pharmacies. Hospital reps covered major teaching hospitals, the few AEs did their thing. This whole "we need an army of 'specialty' reps to see sub specialists" was a trojan horse used to pad Merck and Pfizer's field force head counts. Mostly the latter, starting in the late 90s.
    Of course, after those two did it, Novartis, AZ, and Glaxo followed suit because they refused to be out-manned in the field. Then, because we are a copycat industry, everyone added specialty field forces, further adding to the swarms of reps milling about most towns, desperately vying for signatures and lunches.

    Think of it from a MDs perspective: in 4 years, the number of reps FROM EACH COMPANY in your office selling some statin, ED drug, ARB or quinolone went from two….. to five or six. Multiply that multiplication by the number of Big Pharma companies!
     
  19. anonymous

    anonymous Guest

    Originally, the Novo Nordisk of 2001, 2 DCSs per territory calling primarily on Endos and their DEs first and then fill in our day with PCs.
     
  20. anonymous

    anonymous Guest


    Thank you! Geez it's not rocket science, but if we don't have multiple layers of reps to manage how does the ET justify its existence. The post bahahaing about DCS calling on Endos! Tell me one thing different that the glorified EDCS's do??